Nextferm Technologies Valuation Multiples

Nextferm Technologies is valued at $3M as of October 2026.

Nextferm Technologies Overview

About Nextferm Technologies

Nextferm Technologies Ltd is engaged in the research, development, production, and marketing of yeast-based technologies and products. Its products namely Astaferm and ProteVin mainly used by the food industry, including food additives, animal protein substitutes, and other products. Astaferm is an astaxanthin-rich extract derived from the Phaffia yeast.


Founded

2013

HQ

Israel

Employees

19

Financials (Last FY)

Revenue: -
Net Income: -

EV

$9M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Nextferm Technologies Stock Performance

Nextferm Technologies has current market cap of $3M, and enterprise value of $9M.

Market Cap Evolution


Nextferm Technologies' stock price is $8.14.

Nextferm Technologies share price decreased by 9.6% in the last 30 days.

See more trading valuation data for Nextferm Technologies
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$9M$3M-0.4%-9.6%---

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Nextferm Technologies Valuation Multiples

Nextferm Technologies Financial Valuation Multiples

As of October 9, 2026, Nextferm Technologies has market cap of $3M and EV of $9M.

LTMLast FY202320242025202620272028

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Nextferm Technologies Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Valuation Multiples Across 230+ Verticals

Nextferm Technologies Competitors

Nextferm Technologies competitors include Moolec Science, Planethic Group, Elixinol Wellness, Glia Nova, Green Zebras, Above Food, Sativus Tech, Modern Plant Based Foods, Plant Advanced Technologies and Nutriplant.

Most Nextferm Technologies public comparables operate across Bioindustrials and Plant-Based Food.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Moolec Science$334M($111M)0.2x-(0.7x)-
Planethic Group$13M($3M)1.1x-(5.1x)-
Elixinol Wellness$11M($3M)0.4x-(1.3x)-
Glia Nova-($56K)--(38.5x)-
Green Zebras$322K($359K)12.1x-(10.9x)-
Above Food$259M($27M)0.0x-(0.0x)-
Sativus Tech-($1M)--(3.3x)-
Modern Plant Based Foods$399K($440K)4.5x-(4.1x)-

This data is available for Pro users. Sign up to see all Nextferm Technologies competitors and their valuation data.

Start Free Trial

Nextferm Technologies VC Funding History

Before going public, Nextferm Technologies raised $6M in total equity funding, across 2 rounds.


Nextferm Technologies Funding Rounds

DateStageInvestorsRaisedValuationRev. MultipleDeal Summary
May-24Strategic investmentArancia International$957K-Nextferm's shareholders approved a private placement to a group of investors on May 16, 2024. Arancia International subscribed ILS 1.84 million for 5,030,063 ordinary shares and 2,515,032 options, while the completed placement raised approximately ILS 3.56 million in total. Together with the related shareholder Inmobiliaria Tierra de Occidente, the transaction gave Arancia a controlling block under Israeli company law. The placement strengthened Arancia's position from an existing interested shareholder to a central owner of the listed nutrition-technology company. The company develops fermentation-derived nutrition ingredients, including yeast-based protein and astaxanthin products for food, supplements and animal nutrition. Its ProteVin protein is designed as a neutral-tasting alternative for food formulations, while Astaferm supplies a fermentation-derived antioxidant ingredient. Nextferm's production and development model is intended to deliver consistent functional ingredients at industrial scale.
May-16Series A-$5M--

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Nextferm Technologies

When was Nextferm Technologies founded?Nextferm Technologies was founded in 2013.
Where is Nextferm Technologies headquartered?Nextferm Technologies is headquartered in Israel.
How many employees does Nextferm Technologies have?As of today, Nextferm Technologies has over 19 employees.
Is Nextferm Technologies publicly listed?Yes, Nextferm Technologies is a public company listed on Tel Aviv Stock Exchange.
What is the stock symbol of Nextferm Technologies?Nextferm Technologies trades under NXFR.M ticker.
When did Nextferm Technologies go public?Nextferm Technologies went public in 2021.
Who are competitors of Nextferm Technologies?Nextferm Technologies main competitors include Moolec Science, Planethic Group, Elixinol Wellness, Glia Nova, Green Zebras, Above Food, Sativus Tech, Modern Plant Based Foods, Plant Advanced Technologies, Nutriplant.
What is the current market cap of Nextferm Technologies?Nextferm Technologies' current market cap is $3M.
Is Nextferm Technologies profitable?No, Nextferm Technologies is not profitable.
How many companies Nextferm Technologies has acquired to date?Nextferm Technologies hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Nextferm Technologies has invested to date?Nextferm Technologies hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Nextferm Technologies

Lists including Nextferm Technologies

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial